Vivanza Biosciences Q2 Results

  • BSE: 530057
  • NSE: -
  • ISIN: INE984E01035
  • Sector: Biotechnology & Drugs
BSE
4.090.06 (1.49%)
Volume1.77 L
Updated: Mon 25 Nov, 2024 | 15:26:10
NSE
This stock is not traded on NSE
Today: 4.02
4.23
52-Wk: 3.36
11.72

Q2 Results Highlights

  • Total Income
    ₹3.00 Cr.
    (23.02%)
  • Operating Profit
    ₹0.11 Cr.
    (-70.44%)
  • Profit After Tax
    ₹0.02 Cr.
    (-94.17%)
  • Operating Margin
    3.50%
    (-16.04%)
Note: Comparison is on YoY basis

Quarterly - Vivanza Biosciences Q2 Results

*All figures in crores except per share values
Fiscal PeriodSep 24Jun 23QoQ CompSep 23YoY Comp
Total Revenue 3.009.23-%7.62-%
Selling/ General/ Admin Expenses Total 0.140.12-%0.12-%
Depreciation/ Amortization 0.000.00-%0.00-%
Other Operating Expenses Total 0.040.09-%0.05-%
Total Operating Expense 2.908.64-%7.30-%
Operating Income 0.110.59-%0.32-%
Net Income Before Taxes 0.020.49-%0.26-%
Net Income 0.020.49-%0.26-%
Diluted Normalized EPS 0.000.12-%0.07-%

Recommended For You

    More Recommendations

    Trending Stocks

      Subscribe to Our Newsletter

      Get daily newsletters around different themes from livemint.

      Subscribe
      HomeMarketsPremiumInstant LoanMint Shorts